Tuberculosis Roars Back

A global alliance forms to speed development of new drugs

In early October, an unusual alliance of 25 government and international health agencies, drug companies, and philanthropic foundations will meet in Bangkok to lay out their strategy for a new world war. The mutual enemy is tuberculosis, one of mankind's oldest scourges, and rapidly becoming one of its deadliest once again. The Global Alliance for TB Drug Development, the first international disease effort of its kind, plans to issue a blueprint on Oct. 10 for the development of the first new drugs to fight TB in more than 30 years--and, ultimately, of a vaccine that may one day eradicate the disease.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.